{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:18:01Z","timestamp":1792815481560,"version":"4.5.0"},"reference-count":120,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:p>Many of the major diseases, including cardiovascular disease, are widely recognized as inflammatory diseases. MCP-1 (monocyte chemotactic protein-1) plays a critical role in the development of cardiovascular diseases. MCP-1, by its chemotactic activity, causes diapedesis of monocytes from the lumen to the subendothelial space where they become foam cells, initiating fatty streak formation that leads to atherosclerotic plaque formation. Inflammatory macrophages probably play a role in plaque rupture and the resulting ischaemic episode as well as restenosis after angioplasty. There is strong evidence that MCP-1 plays a major role in myocarditis, ischaemia\/reperfusion injury in the heart and in transplant rejection. MCP-1 also plays a role in cardiac repair and manifests protective effects under certain conditions. Such protective effects may be due to the induction of protective ER (endoplasmic reticulum) stress chaperones by MCP-1. Under sustained ER stress caused by chronic exposure to MCP-1, the protection would break down resulting in the development of heart failure. MCP-1 is also involved in ischaemic angiogenesis. The recent advances in our understanding of the molecular mechanisms that might be involved in the roles that MCP-1 plays in cardiovascular disease are reviewed. The gene expression changes induced by the signalling events triggered by MCP-1 binding to its receptor include the induction of a novel zinc-finger protein called MCPIP (MCP-1-induced protein), which plays critical roles in the development of the pathophysiology caused by MCP-1 production. The role of the MCP-1\/CCR2 (CC chemokine receptor 2) system in diabetes, which is a major risk factor for cardiovascular diseases, is also reviewed briefly. MCP-1\/CCR2- and\/or MCPIP-targeted therapeutic approaches to intervene in inflammatory diseases, including cardiovascular diseases, may be feasible.<\/jats:p>","DOI":"10.1042\/cs20080581","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T15:09:58Z","timestamp":1246547398000},"page":"95-109","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":251,"title":["Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications"],"prefix":"10.1042","volume":"117","author":[{"given":"Jianli","family":"Niu","sequence":"first","affiliation":[{"name":"Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 4000 Central FL Blvd, Orlando, FL 32816, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pappachan\u00a0E.","family":"Kolattukudy","sequence":"additional","affiliation":[{"name":"Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 4000 Central FL Blvd, Orlando, FL 32816, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"2021113011060329800_B1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.physiol.68.040104.124611","article-title":"Protecting the pump: controlling myocardial inflammatory response","volume":"68","author":"Taqueti","year":"2005","journal-title":"Annu. Rev. Physiol."},{"key":"2021113011060329800_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tcm.2003.09.003","article-title":"The role of innate immune responses in the heart in health and disease","volume":"14","author":"Knuefermann","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"key":"2021113011060329800_B3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1517\/14728222.7.1.35","article-title":"Targeting monocyte chemoattractant protein-1 signalling in disease","volume":"7","author":"Dawson","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"2021113011060329800_B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mlc.2000.108154","article-title":"Chemokines, leukocytes, and atherosclerosis","volume":"136","author":"Gerszten","year":"2000","journal-title":"J. Lab. Clin. Med."},{"key":"2021113011060329800_B5","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"2","author":"Gu","year":"1998","journal-title":"Mol. Cell"},{"key":"2021113011060329800_B7","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1582-4934.2008.00261.x","article-title":"Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels","volume":"4","author":"Zhong","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"2021113011060329800_B8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI5624","article-title":"MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B","volume":"103","author":"Gosling","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2021113011060329800_B9","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.168.6.2953","article-title":"IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodelling","volume":"168","author":"Zhu","year":"2002","journal-title":"J. Immunol."},{"key":"2021113011060329800_B10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2\u2212 mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"key":"2021113011060329800_B11","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.ATV.18.12.1983","article-title":"Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL","volume":"18","author":"Han","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hq0402.105720","article-title":"CCR2 deficiency decreases intimal hyperplasia after arterial injury","volume":"22","author":"Roque","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0021-9150(01)00423-3","article-title":"Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G\/G genotype in CAD patients","volume":"158","author":"Szalai","year":"2001","journal-title":"Atherosclerosis"},{"key":"2021113011060329800_B14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00109-003-0435-x","article-title":"Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65\u00a0years of age","volume":"81","author":"Ortlepp","year":"2003","journal-title":"J. Mol. Med."},{"key":"2021113011060329800_B15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2005.11.014","article-title":"Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population","volume":"188","author":"Bjarnadottir","year":"2006","journal-title":"Atherosclerosis"},{"key":"2021113011060329800_B16","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.ATV.0000038486.48400.E7","article-title":"Val64Ile polymorphism in the C-C chemokine receptor 2 is associated with reduced coronary artery calcification","volume":"22","author":"Valdes","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B17","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/art.21962","article-title":"RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study","volume":"54","author":"Yao","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2021113011060329800_B18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0735-1097(00)01110-4","article-title":"Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes","volume":"37","author":"Aukrust","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011060329800_B19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-5273(01)00454-5","article-title":"Chemokines in patients with ischemic heart disease and the effect of coronary angioplasty","volume":"80","author":"Economou","year":"2001","journal-title":"Int. J. Cardiol."},{"key":"2021113011060329800_B20","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011060329800_B21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2261-7-30","article-title":"Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study","volume":"7","author":"Tang","year":"2007","journal-title":"BMC Cardiovasc. Disord."},{"key":"2021113011060329800_B22","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2007.06.057","article-title":"Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial","volume":"50","author":"de\u00a0Lemos","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011060329800_B23","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jacc.2006.01.073","article-title":"Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque","volume":"47","author":"Marfella","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011060329800_B24","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1161\/01.CIR.0000018603.67989.71","article-title":"Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits","volume":"105","author":"Mori","year":"2002","journal-title":"Circulation"},{"key":"2021113011060329800_B25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/01.RES.70.2.314","article-title":"JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells","volume":"70","author":"Taubman","year":"1992","journal-title":"Circ. Res."},{"key":"2021113011060329800_B26","first-page":"I","article-title":"Monocyte chemoattractant protein antibody inhibits restenosis in the rabbit atherosclerotic model","volume":"88","author":"Guzman","year":"1993","journal-title":"Circulation"},{"key":"2021113011060329800_B27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000020561.03244.7E","article-title":"Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys","volume":"90","author":"Egashira","year":"2002","journal-title":"Circ. Res."},{"key":"2021113011060329800_B28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/hh0402.105956","article-title":"Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted","volume":"90","author":"Horvath","year":"2002","journal-title":"Circ. Res."},{"key":"2021113011060329800_B29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.CIR.95.3.693","article-title":"Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium","volume":"95","author":"Kumar","year":"1997","journal-title":"Circulation"},{"key":"2021113011060329800_B30","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.CIR.95.3.684","article-title":"Complement C5a, TGF-\u03b21, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion","volume":"95","author":"Birdsall","year":"1997","journal-title":"Circulation"},{"key":"2021113011060329800_B31","first-page":"195","article-title":"Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1","volume":"79","author":"Ono","year":"1999","journal-title":"Lab. Invest."},{"key":"2021113011060329800_B32","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/01.CIR.0000092890.29552.22","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"108","author":"Hayashidani","year":"2003","journal-title":"Circulation"},{"key":"2021113011060329800_B33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)63309-3","article-title":"Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction","volume":"165","author":"Kaikita","year":"2004","journal-title":"Am. J. Pathol."},{"key":"2021113011060329800_B34","first-page":"101","article-title":"Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle","volume":"152","author":"Kolattukudy","year":"1998","journal-title":"Am. J. Pathol."},{"key":"2021113011060329800_B35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.yjmcc.2004.05.028","article-title":"Duality of innate stress responses in cardiac injury, repair, and remodeling","volume":"37","author":"Wilson","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011060329800_B36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jmcc.2001.1503","article-title":"Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death","volume":"34","author":"Tarzami","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011060329800_B37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbrc.2005.07.168","article-title":"MCP-1\/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G\u03b1i-independent pathway","volume":"335","author":"Tarzami","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011060329800_B38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0008-6363(02)00697-1","article-title":"Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK\/JNK1\/2 activation","volume":"57","author":"Martire","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"2021113011060329800_B39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.RES.0000246113.82111.2d","article-title":"Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction","volume":"99","author":"Morimoto","year":"2006","journal-title":"Circ. Res."},{"key":"2021113011060329800_B40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ. Res."},{"key":"2021113011060329800_B41","doi-asserted-by":"crossref","first-page":"H1411","DOI":"10.1152\/ajpheart.01378.2005","article-title":"Activation of endoplasmic reticulum stress response during the development of ischemic heart disease","volume":"291","author":"Azfer","year":"2006","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"2021113011060329800_B42","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.bbrc.2006.05.077","article-title":"Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78","volume":"345","author":"Shintani-Ishida","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011060329800_B43","first-page":"449","article-title":"Preinduced molecular chaperones in the endoplasmic reticulum protect cardiomyocytes from lethal injury","volume":"34","author":"Zhang","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"2021113011060329800_B44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.lfs.2007.08.015","article-title":"Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78","volume":"81","author":"Pan","year":"2007","journal-title":"Life Sci."},{"key":"2021113011060329800_B45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-2776(08)00604-4","article-title":"Pathogenesis of myocarditis and dilated cardiomyopathy","volume":"99","author":"Cihakova","year":"2008","journal-title":"Adv. Immunol."},{"key":"2021113011060329800_B46","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.4049\/jimmunol.139.11.3630","article-title":"Cardiac myosin induces myocarditis in genetically predisposed mice","volume":"139","author":"Neu","year":"1987","journal-title":"J. Immunol."},{"key":"2021113011060329800_B47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-5728(99)00087-9","article-title":"C-protein in the skeletal muscle induces sever autoimmune polymyositis in Lewis rats","volume":"98","author":"Kohyama","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"2021113011060329800_B48","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.173.5.3535","article-title":"C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy","volume":"173","author":"Matsumoto","year":"2004","journal-title":"J. Immunol."},{"key":"2021113011060329800_B49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/08916930290016538","article-title":"Levels of MCP-1 and GM-CSF mRNA correlated with inflammatory cytokines mRNA levels in experimwntal autoimmune myocarditis in rats","volume":"35","author":"Kobayashi","year":"2002","journal-title":"Autoimmunity"},{"key":"2021113011060329800_B50","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1161\/CIRCULATIONAHA.105.572396","article-title":"Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1\u03b1 in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy","volume":"112","author":"G\u00f6ser","year":"2005","journal-title":"Circulation"},{"key":"2021113011060329800_B51","doi-asserted-by":"crossref","first-page":"12548","DOI":"10.1128\/JVI.78.22.12548-12556.2004","article-title":"Coxsackievirus group B type\u00a03 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis","volume":"78","author":"Shen","year":"2004","journal-title":"J. Virol."},{"key":"2021113011060329800_B52","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.108.182865","article-title":"Chemokines and transplant vasculopathy","volume":"103","author":"Belperio","year":"2008","journal-title":"Circ. Res."},{"key":"2021113011060329800_B53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.healun.2007.02.006","article-title":"Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy","volume":"26","author":"Yin","year":"2007","journal-title":"J. Heart Lung Transplant."},{"key":"2021113011060329800_B54","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1053-2498(02)00443-6","article-title":"Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy","volume":"21","author":"Horiguchi","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"2021113011060329800_B55","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1073\/pnas.90.13.6086","article-title":"Early and persistent induction of monocyte chemoattractant protein-1 in rat cardiac allografts","volume":"90","author":"Russell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011060329800_B56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.athoracsur.2008.03.073","article-title":"Immunological link between primary graft dysfunction and chronic lung allograft rejection","volume":"86","author":"Bharat","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"2021113011060329800_B57","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.gt.3302765","article-title":"Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival","volume":"13","author":"Fleury","year":"2006","journal-title":"Gene Ther."},{"key":"2021113011060329800_B58","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.ATV.0000141045.49616.6f","article-title":"Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy","volume":"24","author":"Saiura","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B59","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/01.tp.0000266892.69117.9a","article-title":"Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection","volume":"83","author":"Haskova","year":"2007","journal-title":"Transplantation"},{"key":"2021113011060329800_B60","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.172.2.767","article-title":"Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine\/chemokine receptor function In vivo","volume":"172","author":"Abdi","year":"2004","journal-title":"J. Immunol."},{"key":"2021113011060329800_B61","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.4049\/jimmunol.171.12.6929","article-title":"Blocking the monocyte chemoattractant protein-1\/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism","volume":"171","author":"Lee","year":"2003","journal-title":"J. Immunol."},{"key":"2021113011060329800_B62","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.healun.2004.07.018","article-title":"Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis","volume":"24","author":"Hognestad","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"2021113011060329800_B63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1432-2277.2003.tb00216.x","article-title":"Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants: a longitudinal study","volume":"16","author":"de\u00a0Groot-Kruseman","year":"2003","journal-title":"Transplant. Int."},{"key":"2021113011060329800_B64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1053-2498(00)00325-9","article-title":"Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection","volume":"20","author":"de\u00a0Groot-Kruseman","year":"2001","journal-title":"J. Heart Lung Transplant."},{"key":"2021113011060329800_B65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI200112214","article-title":"Critical role for the chemokine MCP-1\/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome","volume":"108","author":"Belperio","year":"2001","journal-title":"J. Clin. Invest."},{"key":"2021113011060329800_B66","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00007890-200301150-00013","article-title":"Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants","volume":"75","author":"Fahmy","year":"2003","journal-title":"Transplantation"},{"key":"2021113011060329800_B67","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type\u00a02 diabetes mellitus: insights from mechanistic studies","volume":"371","author":"Mazzone","year":"2008","journal-title":"Lancet"},{"key":"2021113011060329800_B68","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van\u00a0Gaal","year":"2006","journal-title":"Nature"},{"key":"2021113011060329800_B69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"2021113011060329800_B70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"5","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"2021113011060329800_B71","first-page":"798","article-title":"Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein e-deficient mice","volume":"6","author":"Ohman","year":"2007","journal-title":"Circulation"},{"key":"2021113011060329800_B72","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1161\/CIRCRESAHA.107.152165","article-title":"The macrophage at the crossroads of insulin resistance and atherosclerosis","volume":"100","author":"Liang","year":"2007","journal-title":"Circ. Res."},{"key":"2021113011060329800_B73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2021113011060329800_B74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-\u03b2 links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"key":"2021113011060329800_B75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"key":"2021113011060329800_B76","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein-1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011060329800_B77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/13813450601094672","article-title":"Monocyte chemoattractant protein-1 \u2013 a major contributor to the inflammatory process associated with diabetes","volume":"112","author":"Dragomir","year":"2006","journal-title":"Arch. Physiol. Biochem."},{"key":"2021113011060329800_B78","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbrc.2006.03.197","article-title":"Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus","volume":"344","author":"Mine","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011060329800_B79","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2021113011060329800_B80","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","article-title":"Overexpression of MCP-1 in adipose tissues causes macrophage recruitment and insulin resistance","volume":"281","author":"Kamei","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021113011060329800_B81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2021113011060329800_B82","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/ATVBAHA.108.168633","article-title":"Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db\/db mice","volume":"28","author":"Tamura","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011060329800_B83","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2337\/db07-1061","article-title":"Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue","volume":"57","author":"Kirk","year":"2008","journal-title":"Diabetes"},{"key":"2021113011060329800_B84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.185.1.99","article-title":"Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1","volume":"185","author":"Sarafi","year":"1997","journal-title":"J. Exp. Med."},{"key":"2021113011060329800_B85","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00125-004-1494-4","article-title":"Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type\u00a02 diabetes mellitus","volume":"47","author":"Simeoni","year":"2004","journal-title":"Diabetologia"},{"key":"2021113011060329800_B86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1126\/science.1103160","article-title":"Endoplasmic reticulum stress links obesity, insulin action, and type\u00a02 diabetes","volume":"306","author":"Ozcan","year":"2004","journal-title":"Science"},{"key":"2021113011060329800_B87","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type\u00a02 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"2021113011060329800_B88","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type\u00a02 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021113011060329800_B89","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.0000057997.77714.72","article-title":"VEGFR-1-selective VEGF homologue PIGF is arteriogenic: evidence for a monocyte-mediated mechanism","volume":"92","author":"Pipp","year":"2003","journal-title":"Circ. Res."},{"key":"2021113011060329800_B90","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F","article-title":"Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1","volume":"82","author":"Goede","year":"1999","journal-title":"Int. J. Cancer"},{"key":"2021113011060329800_B91","doi-asserted-by":"crossref","first-page":"H1422","DOI":"10.1152\/ajpheart.00506.2002","article-title":"Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1","volume":"284","author":"Voskuil","year":"2003","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"2021113011060329800_B92","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2004.04.046","article-title":"Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization","volume":"44","author":"Niiyama","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011060329800_B93","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.RES.0000099245.08637.CE","article-title":"Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells","volume":"93","author":"Fujiyama","year":"2003","journal-title":"Circ. Res."},{"key":"2021113011060329800_B94","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.87.5.378","article-title":"Contribution of monocytes\/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium","volume":"87","author":"Moldovan","year":"2000","journal-title":"Circ. Res."},{"key":"2021113011060329800_B95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.V96.1.34","article-title":"Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression","volume":"96","author":"Salcedo","year":"2000","journal-title":"Blood"},{"key":"2021113011060329800_B96","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood-2004-08-3178","article-title":"Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A","volume":"105","author":"Hong","year":"2005","journal-title":"Blood"},{"key":"2021113011060329800_B97","doi-asserted-by":"crossref","first-page":"14542","DOI":"10.1074\/jbc.M802139200","article-title":"Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)","volume":"283","author":"Niu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021113011060329800_B98","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.177.4.2651","article-title":"CCL2 regulates angiogenesis via activation of Ets-1 transcription factor","volume":"177","author":"Stamatovic","year":"2006","journal-title":"J. Immunol."},{"key":"2021113011060329800_B99","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4049\/jimmunol.148.8.2423","article-title":"Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes","volume":"148","author":"Jiang","year":"1992","journal-title":"J. Immunol."},{"key":"2021113011060329800_B100","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"key":"2021113011060329800_B101","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.RES.82.11.1130","article-title":"Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction","volume":"82","author":"Takemura","year":"1998","journal-title":"Circ. Res."},{"key":"2021113011060329800_B102","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.yjmcc.2006.03.010","article-title":"Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac- specific expression of MCP-1","volume":"40","author":"Niu","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113011060329800_B103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cardiores.2006.03.008","article-title":"Monocyte-specific Bcl-2 expression attenuates inflammation and heart failure in monocyte chemoattractant protein-1 (MCP-1)-induced cardiomyopathy","volume":"71","author":"Niu","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"2021113011060329800_B104","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cvr\/cvn035","article-title":"MCP-1 induces cardioprotection against ischaemia\/reperfusion injury: role of reactive oxygen species","volume":"78","author":"Morimoto","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"2021113011060329800_B105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cardiores.2006.11.031","article-title":"Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy","volume":"73","author":"Niu","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"2021113011060329800_B106","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1073\/pnas.0608799103","article-title":"Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice","volume":"103","author":"Haudek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011060329800_B107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.106.646091","article-title":"Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy","volume":"115","author":"Frangogiannis","year":"2007","journal-title":"Circulation"},{"key":"2021113011060329800_B108","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152807780832265","article-title":"MCP-1\/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy","volume":"6","author":"Xia","year":"2007","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"2021113011060329800_B109","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jlb.57.5.782","article-title":"A role for C-C chemokines in fibrotic lung disease","volume":"57","author":"Smith","year":"2007","journal-title":"J. Leukocyte Biol."},{"key":"2021113011060329800_B110","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.4049\/jimmunol.167.8.4368","article-title":"Protection from pulmonary fibrosis in the absence of CCR2 signalling","volume":"167","author":"Moore","year":"2001","journal-title":"J. Immunol."},{"key":"2021113011060329800_B111","doi-asserted-by":"crossref","first-page":"F1075","DOI":"10.1152\/ajprenal.00349.2001","article-title":"Existence of a regulatory loop between MCP-1 and TGF-\u03b2 in glomerular immune injury","volume":"283","author":"Wolf","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011060329800_B112","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1074\/jbc.271.30.17779","article-title":"Costimulation of fibroblast collagen and transforming growth factor \u03b21 gene expression by monocyte chemoattractant protein-1 via specific receptors","volume":"271","author":"Gharaee-Kermani","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021113011060329800_B113","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.4049\/jimmunol.164.12.6174","article-title":"Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 \u03b1 loop","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J. Immunol."},{"key":"2021113011060329800_B114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1357-2725(96)00117-3","article-title":"Apoptosis during wound healing, fibrocontractive disease and vascular wall injury","volume":"29","author":"Desmouliere","year":"1997","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"2021113011060329800_B115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.RES.0000220106.64661.71","article-title":"Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction","volume":"98","author":"Zhou","year":"2006","journal-title":"Circ. Res."},{"key":"2021113011060329800_B116","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1074\/jbc.M707861200","article-title":"A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages","volume":"283","author":"Liang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021113011060329800_B117","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.RES.0000223483.12225.80","article-title":"MCP-1 induces a novel transcription factor with proapoptotic activity","volume":"98","author":"Bidzhekov","year":"2006","journal-title":"Circ. Res."},{"key":"2021113011060329800_B118","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.1995.304","article-title":"Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin","volume":"48","author":"Kim","year":"1995","journal-title":"Kidney Int."},{"key":"2021113011060329800_B119","doi-asserted-by":"crossref","first-page":"G1259","DOI":"10.1152\/ajpgi.00435.2004","article-title":"Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis","volume":"288","author":"Bhatia","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113011060329800_B120","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2007.06.148","article-title":"Inhibition of MCP-1\/CCR2 pathway ameliorates the development of diabetic nephropathy","volume":"360","author":"Kanamori","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/117\/3\/95\/439061\/cs1170095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/117\/3\/95\/439061\/cs1170095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T21:38:25Z","timestamp":1685050705000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/117\/3\/95\/77705\/Role-of-MCP-1-in-cardiovascular-disease-molecular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,2]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20080581","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,2]]}}}